Brethine


Also found in: Wikipedia.

Brethine

 [breth´ēn]
trademark for preparations sof terbutaline sulfate, a bronchodilator.

Brethine

a trademark for a beta2 receptor agonist agent (terbutaline sulfate).
References in periodicals archive ?
On March 1, 2004, before the market opened, aaiPharma's Board of Directors announced that it had become aware of unusual sales in the Company's Brethine and Darvocet product lines during the second half of 2003.
Defendants emphasized increased revenues throughout the Class Period, fueled by strong sales of pharmaceutical products including sales of Brethine, an asthma medication.
On February 5, 2004, before the market opened, defendants shocked the market by announcing that due to excessive product returns of products such as Brethine, and necessary additions to product return reserves, fourth quarter net revenues were reduced by $15.
Several theories have been discussed regarding the physiologic and chemical effects of Brethine.
Brethine is a medication commonly used for prevention and reversal of bronchospasm, but in obstetrics it helps to prevent premature labor.
His omission prevented timely serial monitoring to determine if the contractions were causing the cervical change, and if the prescribed tocolytic, Brethine, was working or needed to be replaced.
Brethine, which is marketed by Novartis for the prevention and reversal of bronchospasm, had sales of approximately $15 million in the U.
As the first generic version of Brethine, this product will offer both patients and payors a cost-effective alternative to the brand.
Horizon Pharmaceutical Corporation, a privately held emerging pharmaceutical company, and Novartis Pharmaceuticals Corporation, a leader in Life Sciences, announced today a promotion agreement enabling Horizon to promote Novartis's Brethine (R), a prescription respiratory medicine for the treatment of asthma to physicians on behalf of Novartis.